key: cord-0690283-0ifl93a4 authors: Zhang, Ping; He, Zhigang; Yu, Gang; Peng, Dan; Feng, Yikuan; Ling, Jianmin; Wang, Ye; Li, Shusheng; Bian, Yi title: The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients date: 2020-06-05 journal: Clin Nutr DOI: 10.1016/j.clnu.2020.05.051 sha: de10babace18325d667992c94d97b2a02c0d053b doc_id: 690283 cord_uid: 0ifl93a4 Summary Background and Aims In the newly emerged Coronavirus Disease 2019 (COVID-19) disaster, little is known about the nutritional risks for critically ill patients. It is also unknown whether the modified Nutrition Risk in the Critically ill (mNUTRIC) score is applicable for nutritional risk assessment in intensive care unit (ICU) COVID-19 patients. We set out to investigate the applicability of the mNUTRIC score for assessing nutritional risks and predicting outcomes for these critically ill COVID-19 patients. Methods This retrospective observational study was conducted in three ICUs which had been specially established and equipped for COVID-19 in Wuhan, China. The study population was critically ill COVID-19 patients who had been admitted to these ICUs between January 28 and February 21, 2020. Exclusion criteria were as follows: 1) patients of <18 years; 2) patients who were pregnant; 3) length of ICU stay of <24 hours; 4) insufficient medical information available. Patients’ characteristics and clinical information were obtained from electronic medical and nursing records. The nutritional risk for each patient was assessed at their ICU admission using the mNUTRIC score. A score of ≥5 indicated high nutritional risk. Mortality was calculated according to patients’ outcomes following 28 days of hospitalization in ICU. Results A total of 136 critically ill COVID-19 patients with a median age of 69 years (IQR: 57-77), 86 (63%) males and 50 (37%) females, were included in the study. Based on the mNUTRIC score at ICU admission, a high nutritional risk (≥5 points) was observed in 61% of the critically ill COVID-19 patients, while a low nutritional risk (<5 points) was observed in 39%. The mortality of ICU 28-day was significantly higher in the high nutritional risk group than in the low nutritional risk group (87% vs 49%, P <0.001). Patients in the high nutritional risk group exhibited significantly higher incidences of acute respiratory distress syndrome, acute myocardial injury, secondary infection, shock and use of vasopressors. Additionally, use of a multivariate Cox analysis showed that patients with high nutritional risk had a higher probability of death at ICU 28-day than those with low nutritional risk (adjusted HR =2.01, 95% CI: 1.22-3.32, P =0.006). Conclusions A large proportion of critically ill COVID-19 patients had a high nutritional risk, as revealed by their mNUTRIC score. Patients with high nutritional risk at ICU admission exhibited significantly higher mortality of ICU 28-day, as well as twice the probability of death at ICU 28-day than those with low nutritional risk. Therefore, the mNUTRIC score may be an appropriate tool for nutritional risk assessment and prognosis prediction for critically ill COVID-19 patients. patients. It is also unknown whether the modified Nutrition Risk in the Critically ill 48 (mNUTRIC) score is applicable for nutritional risk assessment in intensive care unit 49 (ICU) COVID-19 patients. We set out to investigate the applicability of the 50 mNUTRIC score for assessing nutritional risks and predicting outcomes for these 51 critically ill COVID-19 patients. Methods: This retrospective observational study was conducted in three ICUs which 53 had been specially established and equipped for COVID-19 in Wuhan, China. The 54 study population was critically ill COVID-19 patients who had been admitted to these 55 ICUs between January 28 and February 21, 2020. Exclusion criteria were as follows: should be recognized earlier during ICU stay, as such a risk is directly associated with 98 adverse clinical outcomes (4). Additionally, these patients could benefit more from 99 nutritional interventions than those at lower nutritional risk (5). Therefore, adequate 100 assessment of nutritional risk should be a standard procedure for ICU patients. (NUTRIC) score, another recommended screening tool, was the first to be developed 105 specifically for ICU patients (5, 6). In its newer, briefer version, the modified 106 NUTRIC (mNUTRIC) score, the use of Interleukin-6 (IL-6) as a variable was 107 excluded (7). The study population was critically ill COVID-19 patients who had been 134 admitted to one of the three ICUs between January 28 and February 21, 2020. All Patients were excluded from the study if they were: 1) <18 years; 2) pregnant; 138 3) had a length of ICU stay <24 hours; 4) had insufficient medical information. Table 1 . Based on mNUTRIC scores at ICU admission, a high nutritional risk (≥5 points) 213 was observed in 61% of critically ill COVID-19 patients. A low nutritional risk (<5 214 points) was observed in 39%. 215 We divided the study population into high nutritional risk (mNUTRIC score ≥5 216 points) and low nutritional risk (mNUTRIC score <5 points) groups. Respective 217 differences between these two groups were annotated and can be seen in Table 2 . The We compared the scoring details of each item in the mNUTRIC score among 237 survivals and non-survivals at ICU 28-day, which can be seen in Table 3 . We observed 238 significant distribution differences between the two groups in the items of age, 239 APACHE II score, SOFA score and comorbidities. Compared to the survivals, the 240 12 non-survivals were significantly older, had higher APACHE II and SOFA scores and 241 more comorbidities. Finally, the non-survival group exhibited significantly higher 242 mNUTRIC score comparing to the survival group. However, we did not observe 243 significant difference of pre-ICU hospital LOS in the two groups. During their stay in ICUs, most patients (57%) received enteral nutrition (EN). Some 10% received total parenteral nutrition (TPN), while 22% received EN plus PN. The remaining 11% did not receive any nutritional support as a result of 254 contraindications. For patients receiving EN, the major feeding route was via 255 nasogastric tube (75%). Some 47% received oral feeding, while only 2% were fed via 256 a nasal jejunal tube. EN intolerance occurred in some patients. Vomiting or gastric 257 retention occurred in 32%, while hyperglycemia occurred in 63%. Others included 258 diarrhea (5%) and hypoglycemia (3%). Patients' detailed nutritional status, respective 259 risk and support can be seen in Table 4 . The nutritional risks and applicability of the mNUTRIC score for critically ill 263 COVID-19 patients are largely unknown. In this study, we for the first time report that 264 a large proportion of critically ill COVID-19 patients had a high nutritional risk 265 (mNUTRIC score ≥5 points). Patients with high nutritional risk at ICU admission 266 exhibited significantly higher mortality of ICU 28-day, as well as twice the 267 probability of death at ICU 28-day than those with low nutritional risk. Our data 268 suggest that the mNUTRIC score may be an appropriate tool for nutritional risk 269 assessment and prognosis prediction for critically ill COVID-19 patients. According to a recent report from the Chinese Centers for Disease Control, 14% 271 of confirmed COVID-19 cases are classified as severe and 5% as critically ill (16). While the overall mortality rate of COVID-19 (2%) (16) is much lower than that of . This is in accordance with the characteristics of participants in this 287 study. Early comprehensive evaluation along with high-quality supportive care are 288 urgently needed for patients deemed to be at high risk. 289 We found that a great portion of critically ill COVID-19 patients were at high participants were lower than typical levels, which might reflect a poor nutritional 297 status at ICU admission. One explanation may be that these patients were critically ill, 298 with many of them also having multiple organ dysfunction. This is backed up by the 299 high median APACHE II (18 points) and SOFA (7 points) scores at ICU admission. In summary, our study is the first to investigate the use of the mNUTRIC score 388 for a particular population of critically ill COVID-19 patients. Based on the 389 mNUTRIC score at ICU admission, a high nutritional risk (≥5 points) was observed in 390 61% of these patients. The high nutritional risk group demonstrated significantly 391 higher mortality of ICU 28-day than the low nutritional risk group. Critically ill 392 COVID-19 patients with high nutritional risk at ICU admission were twice as likely to 393 die at ICU 28-day than those with low nutritional risk. Therefore, the mNUTRIC 394 19 score may be an appropriate tool for nutritional risk assessment and prognosis 395 prediction in critically ill COVID-19 patients. Patients with high nutritional risk (mNUTRIC score ≥5 points) had a higher 513 probability of death at ICU 28-day than those with low nutritional risk (mNUTRIC 514 score <5 points) (adjusted HR =2.01, 95% CI: 1.22-3.32, P =0.006). Clinical management of severe acute respiratory infection 440 when novel coronavirus (2019-nCoV) infection is suspected: Interim Guidance Association Between Cardiac 443 Injury and Mortality in Hospitalized Patients Infected With Avian Influenza A (H7N9) Virus. Crit 444 Care Med Comorbid Chronic Diseases and Acute 446 KDIGO clinical practice guidelines for acute kidney injury CDC definitions for nosocomial 451 infections APACHE II: a severity of disease 453 classification system The SOFA 455 (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On 456 behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive 457 Care Medicine Characteristics of and Important Lessons From the Coronavirus 459 Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the World Health Organization. Summary of probable SARS cases with onset of illness from 462 1 Middle East respiratory syndrome coronavirus (MERS-CoV) Use of Nutrition Risk in Critically ill 469 (NUTRIC) Score to Assess Nutritional Risk in Mechanically Ventilated Patients: A Prospective 470 Observational Study Nutritional risk 472 assessment and cultural validation of the modified NUTRIC score in critically ill patients-A 473 multicenter prospective cohort study Enteral Nutrition in the Mechanically Ventilated Patient ESPEN 477 Guidelines on Enteral Nutrition: Intensive care Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, 480 controlled, multicentre, open-label, parallel-group study (NUTRIREA-2) Consensus statement: Academy 483 of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: 484 characteristics recommended for the identification and documentation of adult malnutrition 485 (undernutrition) Calculated decisions: sequential organ failure assessment (SOFA) score Metabolic 489 and nutritional support of critically ill patients: consensus and controversies NUTRIC score use around the world: a 492 systematic review. Rev Bras Ter Intensiva The diagnosis and NUTRIC 494 score of critically ill patients in enteral nutrition are risk factors for the survival time in an 495 intensive care unit? ESPEN 497 guideline on clinical nutrition in the intensive care unit Comparison of 499 nutritional screening and diagnostic tools in diagnosis of severe malnutrition in critically ill 500 patients Association of 502 modified NUTRIC score with 28-day mortality in critically ill patients Total bilirubin, μmol/L ≤26 15 High-sensitivity cardiac troponin I, pg/mL ≤34 High-sensitivity C-reactive protein, mg/L <1 Time from disease onset to ICU admission, median (IQR) GCS score, median (IQR), points APACHE II score, median (IQR), points 21 The authors thank all the included patients and their families, physicians, nurses, 399 dieticians, and all staff. 409 The authors declare no conflicts of interest.